The 12 closest competitors and alternatives to ClearNote Health among biotech companies — ranked by similarity to what ClearNote Health actually does, not by market-cap band.
Subscribe to see ClearNote Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ClearNote Health, Inc. is a pioneer in epigenomic technologies with corporate offices located in San Diego, California. The company has secured funding through SEC Form D filings to advance its biotechnology operations.
ClearNote Health is a biotech company headquartered in United States. Its most recent funding round raised $21.8M in May 2025. Xcout tracks 20 named people at ClearNote Health, including David Mullarkey (Chief Executive Officer). Xcout recorded 1 job posting from ClearNote Health in the last 90 days.
14 more named people on record for ClearNote Health, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $21.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from ClearNote Health in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see ClearNote Health's hiring signals →
Ranked by semantic similarity — how close each company is to ClearNote Health by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Diagnostics/Tools
Adela, Inc. is an epigenomics-focused biotechnology company headquartered in Foster City, California. The company is advancing breakthrough approaches for the early detection of multiple types of cancer through blood tests.
Biotechnology
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Biotechnology
Hepta Bio, Inc. focuses on developing liquid biopsy technology for metabolic dysfunction-associated conditions, with headquarters in California.
Similar biotech company
Sarmal, Inc. is a San Diego-based biotechnology company founded in 2003 that develops next-generation genomic sequencing platforms, whole-genome sequencing technology, and field-deployable nucleic acid diagnostics. The company focuses on innovations in advanced nucleic acid sequencing and target sequence detection.
Similar biotech company
Genalyte is a biotechnology company headquartered in San Diego, California, that provides an on-site blood testing platform. The company's technology delivers real-time lab results directly to clinics in under 30 minutes.
Similar biotech company
Epigenomics AG is a molecular diagnostics company headquartered in Germany. The company also has a wholly owned subsidiary, Epigenomics Inc., based in Seattle, Washington, USA.
Healthcare & Life Sciences
Cognision is a biotechnology research company headquartered in Louisville, Kentucky (with primary offices also noted in Boston, Massachusetts). The firm develops advanced neurological assessment tools and diagnostic technologies.
Healthcare Diagnostics
Clear Health Pass Holdings LLC develops and provides advanced in-vitro diagnostic testing solutions, including saliva and fecal-based health diagnostic collections, genomics, and medical wellness testing. The company serves medical facilities, businesses, and government entities with diagnostic tools spanning areas such as cardiology, diabetes, genetics, women's health, allergies, and drug screening.
Life Sciences
Clarified Precision Medicine is a healthcare company headquartered in San Francisco, California, focused on precision medicine solutions.
Similar biotech company
Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is EpiSwitch, an exclusive technological platform employed for discovering, assessing, validating, and tracking epigenetic biomarkers, specifically referred to as chromosome conformation signatures. These are crucial for developing medical diagnostic kits, predicting disease onset, aiding in diagnosis, and informing therapeutic strategies. The company's key products encompass the EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic tool for forecasting patient responses to checkpoint inhibitor immunotherapy; the EpiSwitch CST (Covid Severity Test), a sophisticated blood test designed to predict the severity of COVID-19 in adults; and the EpiSwitch Explorer Array Kit, which enables high-resolution 3D genome analysis and novel biomarker discovery. Established in 2007, Oxford BioDynamics Plc maintains its headquarters in Oxford, United Kingdom.
Biotechnology
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ClearNote Healthand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →